Stay updated on Pembrolizumab in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in mCRPC Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a site revision: 'Revision: v3.4.2' is listed, with a prior entry for v3.4.1 and a legacy government funding notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:31.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide funding notice and updated the page to revision v3.4.1, removing v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T05:36:31.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and a 'Last Update Submitted that Met QC Criteria' label; capitalization adjusted for 'No FEAR Act Data' and the site revision updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:50:08.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-14T01:13:12.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with California (San Francisco, CA) listed as a study site. The previous California Locations header was removed and the page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:42:45.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-01T17:11:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in mCRPC Clinical Trial page.